Annovis Bio, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2026 Annual Meeting of Stockholders held virtually on June 17, 2026. Annovis Bio, Inc. (ANVS), a Delaware corporation, is an emerging growth company. The record date for the meeting was April 28, 2026.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Results
A total of 21,705,113 shares (62.65% of outstanding common stock) were represented at the meeting. All five proposals submitted were approved:
- Election of Directors: All five nominees (Michael Hoffman, Maria Maccecchini, Claudine Bruck, Reid McCarthy, and Mark White) were elected to serve one-year terms.
- Auditor Ratification: Stockholders approved the appointment of Ernst & Young LLP as the independent auditor.
- Equity Plan Amendment: Stockholders approved an amendment to the 2019 Equity Incentive Plan, increasing the total shares available for issuance from 4,000,000 to 5,500,000 and the annual award limit from 400,000 to 600,000 shares.
- Executive Compensation (Say-on-Pay): The advisory vote on named executive officer compensation was approved.
- Compensation Vote Frequency: Stockholders selected a two-year frequency for future advisory votes on executive compensation.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, specific risks, or contingencies. The document confirms the Board's decision to hold future compensation advisory votes every two years based on the stockholder vote.
Investor Verification Checklist
- Verify the impact of the increased share pool (5.5 million shares) on potential future dilution.
- Review the definitive proxy statement filed on April 30, 2026, for detailed biographies of the newly elected directors.
- Confirm the specific terms of the 2019 Equity Incentive Plan amendment in the company's charter documents.
- Monitor upcoming financial reports for the company's cash burn rate and runway, as this 8-K contains no financial performance data.